Evidence-Based Reviews

Cognitive-behavioral therapy for insomnia: A review of 8 studies

Author and Disclosure Information

 

References

Outcomes

  • A significant improvement in nightmares was noted in both groups (29% of participants showed a clinically-significant reduction in nightmare frequency and 22% of participants achieved remission).
  • CBT-I plus IR was not superior to CBT-I only at postintervention and at 6-month follow-up.

Conclusion

  • Both IR and CBT-I demonstrated efficacy for decreasing nightmare frequency and distress.
  • Combining IR and CBT-I may not provide a synergistic advantage over CBT-I alone for treating PTSD-related nightmares in veterans.

Pages

Recommended Reading

Sleep quality may affect COPD risk in African American smokers
MDedge Psychiatry
COVID-19: Delirium first, depression, anxiety, insomnia later?
MDedge Psychiatry
Less REM sleep tied to higher mortality
MDedge Psychiatry
FDA approves low-sodium treatment option for narcolepsy
MDedge Psychiatry
Pandemic-related stress causing health issues in many Americans
MDedge Psychiatry
Patients with COPD plus sleep problems should be screened for mood disorders
MDedge Psychiatry
‘Long sleep’ or apnea in middle age double risk for Alzheimer’s disease
MDedge Psychiatry
Sleep problems in young children linked to lower QOL in later years
MDedge Psychiatry
Clinical pearls for administering cognitive exams during the pandemic
MDedge Psychiatry
Alzheimer’s disease may affect sleep patterns
MDedge Psychiatry